No photo of John Burnett

View Scopus Profile

John Burnett

Clinical Professor

  • The University of Western Australia (M570), 35 Stirling Highway,

    6009 Perth

    Australia

  • 2777 Citations
  • 30 h-Index
19992019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where John Burnett is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 11 Similar Profiles
Hyperlipoproteinemia Type II Medicine & Life Sciences
Apolipoproteins B Medicine & Life Sciences
Hypobetalipoproteinemias Medicine & Life Sciences
Mutation Medicine & Life Sciences
LDL Cholesterol Medicine & Life Sciences
Lipoproteins Medicine & Life Sciences
Metabolism Chemical Compounds
Lipids Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1999 2019

A genetic risk score predicts coronary artery disease in familial hypercholesterolaemia: enhancing the precision of risk assessment

Ellis, K. L., Hooper, A. J., Pang, J., Chan, D. C., Burnett, J. R., Bell, D. A., Schultz, C. J., Moses, E. K. & Watts, G. F., 30 Sep 2019, In : Clinical Genetics.

Research output: Contribution to journal › Article

Hyperlipoproteinemia Type II
Coronary Artery Disease
Life Style
Atherosclerosis
Coronary Vessels
1 Citation (Scopus)

Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does it Make a Difference in the Clinic?

Chan, D. C., Pang, J., Hooper, A. J., Bell, D. A., Burnett, J. R. & Watts, G. F., Oct 2019, In : Clinical Chemistry. 65, 10, p. 1258-1266

Research output: Contribution to journal › Article

Hyperlipoproteinemia Type II
Lipoprotein(a)
LDL Cholesterol
Cholesterol
Lipids

Lipids and cardiovascular disease

Burnett, J. R., Hooper, A. J. & Hegele, R. A., Feb 2019, In : Pathology. 51, 2, p. 129-130 2 p.

Research output: Contribution to journal › Editorial

4 Citations (Scopus)

Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment

Carr, S. S., Hooper, A. J., Sullivan, D. R. & Burnett, J. R., 1 Feb 2019, In : Pathology. 51, 2, p. 148-154 7 p.

Research output: Contribution to journal › Review article

Apolipoproteins B
LDL Cholesterol
Cardiovascular Diseases
Lipoproteins
LDL Lipoproteins
2 Citations (Scopus)

Update on the diagnosis, treatment and management of rare genetic lipid disorders

Ng, D. M., Burnett, J. R., Bell, D. A., Hegele, R. A. & Hooper, A. J., Feb 2019, In : Pathology. 51, 2, p. 193-201 9 p.

Research output: Contribution to journal › Review article

Projects 2004 2014

Regulation of Triglyceride Rich Lipoprotein Metabolism in Familial Hypercholesterolaemia - Effect of Omega 3 Fatty Acid Ethyl Esters

Chan, D., Watts, G., Burnett, J., Barrett, H., Van Bockxmeer, F. & Sullivan, D.

National Health & Medical Research Council NHMRC

1/01/12 → 31/12/14

Project: Research

Molecular Mechanisms of Inherited Hypocholesterolaemias - Impact of APOB & MTTP Mutations on Lipoprotein Assembly & Secretion

Hooper, A., Burnett, J. & Van Bockxmeer, F.

National Health & Medical Research Council NHMRC

1/01/11 → 31/12/12

Project: Research

Medical & Health Research Infrastructure Fund - Round 13 - Burnett

Burnett, J.

WA Department of Health

1/01/10 → 31/12/10

Project: Research

403908: Lipoprotein Metabolism and Mutations of the APOB Gene Causing Familial Hypobetalipoproteinaemia

Burnett, J., Barrett, H. & Van Bockxmeer, F.

NHMRC Project Grants

1/01/06 → 31/12/08

Project: Research

A Novel Nontruncating Apolipoprotein B Gene Mutation, L343V, Causing Familial Hypobetalipoproteinaemia

Burnett, J., Barrett, H. & Van Bockxmeer, F.

National Heart Foundation

1/01/04 → 31/12/05

Project: Research